Empagliflozin in Renal Transplant Recipients
NCT03157414
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
49
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus
Renal Insufficiency
Safety Issues
Interventions
DRUG:
Empagliflozin
OTHER:
Placebo
Sponsor
Oslo University Hospital